NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
James K Aikins
Rowan University - Glassboro / United States
Medical and Health Sciences / Radiation Oncology
AD Scientific Index ID: 4689241
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
James K Aikins's MOST POPULAR ARTICLES
1-)
Phase II study of mifepristone (RU486) in refractory ovarian cancer Gynecologic oncology 77 (3), 429-432, 2000
2-)
Metastatic cervical cancer and pelvic inflammatory disease in an AIDS patient Gynecologic oncology 54 (3), 372-376, 1994
3-)
Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer Gynecologic oncology 54 (1), 103, 1994
4-)
Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group Gynecologic oncology 110 (3), 329-335, 2008
5-)
Is routine omentectomy of grossly normal omentum helpful in surgery for ovarian cancer? A look at the tumor microenvironment and its clinical implications Gynecologic Oncology 161 (1), 78-82, 2021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept